Stay updated on Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial
Sign up to get notified when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.

Latest updates to the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe site footer revision label changed from v3.7.2 to v3.8.0. The clinical trial record content remains unchanged.SummaryDifference0.1%

- Check20 days agoChange DetectedA banner at the top of the page announces NIH website transition updates and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.5%

- Check27 days agoChange DetectedThe footer now displays site revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.0 to v3.7.1; the study record content remains unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry (v3.7.0) was added to the version history and the previous revision (v3.6.6) was removed from the current listing, updating the record’s revision history.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small site-wide update to the record history interface.SummaryDifference0.1%

Stay in the know with updates to Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lenalidomide+Dexamethasone±Elotuzumab in Untreated Myeloma Clinical Trial page.